E
Ventyx Biosciences, Inc. VTYX
$13.93 $0.060.43% NASDAQ
Recommendation
Prev Close
$13.87
Volume
950,356
Avg Vol (90D)
4,431,943
Market Cap
$995.17M
Dividend & Yield
--
52-Week Range
$0.78 - $25.00
P/E (TTM)
--
EPS (TTM)
-$1.50
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Eli Lilly Stock Rallies as Ventyx Deal Calms Wegovy Concerns
1/13/2026 - MarketBeat
Halper Sadeh LLC Encourages VTYX and SNCY Shareholders to Contact the Firm to Discuss Their Rights
1/21/2026 - Globe Newswire
Ventyx Biosciences, Inc. (NASDAQ:VTYX) Given Average Recommendation of "Reduce" by Analysts
1/21/2026 - MarketBeat
Halper Sadeh LLC Encourages SEE, VTYX, SNCY Shareholders to Contact the Firm to Discuss Their Rights
1/21/2026 - PR Newswire
Stock Market Today, Jan. 20: Corvus Pharmaceuticals Surges After Positive Phase 1 Eczema Drug Data
1/20/2026 - Fool.com Headlines
Ventyx Biosciences, Inc. (NASDAQ:VTYX) Short Interest Update
1/19/2026 - MarketBeat
Could Acquiring Ventyx Biosciences Send Eli Lilly Stock Soaring in 2026?
1/17/2026 - Nasdaq News: Markets
Could Acquiring Ventyx Biosciences Send Eli Lilly Stock Soaring in 2026?
1/17/2026 - Yahoo! Finance: News
Could Acquiring Ventyx Biosciences Send Eli Lilly Stock Soaring in 2026?
1/17/2026 - Fool.com Headlines
Halper Sadeh LLC Encourages ONTF, VTYX, SNCY Shareholders to Contact the Firm to Discuss Their Rights
1/17/2026 - Globe Newswire
Citizens Financial Group Inc. RI Takes Position in Ventyx Biosciences, Inc. $VTYX
1/16/2026 - MarketBeat
Why Eli Lilly (LLY) Stock Is Down Today
1/15/2026 - StockStory Articles
Halper Sadeh LLC Encourages VTYX, PEN, CWAN Shareholders to Contact the Firm to Discuss Their Rights
1/15/2026 - Globe Newswire
Where is Eli Lilly and Company (LLY) Headed According to Analysts?
1/15/2026 - Insider Monkey
$HAREHOLDER ALERT: The M&A Class Action Reminds $hareholders of Upcoming Merger Deadlines FFIC, OCFC, VTYX, and ONTF
1/15/2026 - Globe Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ventyx Biosciences, Inc. - VTYX
1/15/2026 - PR Newswire
Halper Sadeh LLC Encourages VTYX, ONTF, FFIC, OCFC Shareholders to Contact the Firm to Discuss Their Rights
1/14/2026 - Globe Newswire
$HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--FFIC, OCFC, VTYX, and ONTF
1/14/2026 - PR Newswire
Eli Lilly Stock Rallies as Ventyx Deal Calms Wegovy Concerns
1/13/2026 - MarketBeat
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ventyx Biosciences, Inc. - VTYX
1/13/2026 - Globe Newswire
Halper Sadeh LLC Encourages VTYX, ONTF, FFIC, OCFC Shareholders to Contact the Firm to Discuss Their Rights
1/13/2026 - Globe Newswire
$HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger FFIC, OCFC, VTYX, and ONTF
1/13/2026 - Globe Newswire
Halper Sadeh LLC Encourages VTYX, SNCY, EKSO Shareholders to Contact the Firm to Discuss Their Rights
1/13/2026 - PR Newswire
Halper Sadeh LLC Encourages VTYX, FONR, SNCY, FFIC Shareholders to Contact the Firm to Discuss Their Rights
1/12/2026 - PR Newswire
Abivax stock rockets 30% on Eli Lilly takeover speculation
1/12/2026 - Invezz News
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
-$116.44M
EBIT (TTM)
-$116.72M
Net Income (TTM)
-$106.61M
Balance Sheet
Total Assets (Q)
$211.47M
Total Debt (Q)
$10.02M
Total Liabilities (Q)
$20.10M
Book Value Per Share (Q)
$2.68
Cash Flow
Cash from Operations (TTM)
-$87.75M
Cash from Investing (TTM)
$57.66M
Cash from Financing (TTM)
$246.00K
Net Change in Cash (TTM)
-$29.80M
Filings
Filing Date
Thursday, November 6, 2025
Period Date
Tuesday, September 30, 2025
Next Filing
Week of Feb 23 and 27 (est)
Price History
Loading...
Beta
2.92
7-Day Total Return
0.65%
30-Day Total Return
58.30%
60-Day Total Return
139.76%
90-Day Total Return
505.65%
Year to Date Total Return
65.83%
1-Year Total Return
544.91%
2-Year Total Return
586.21%
3-Year Total Return
-60.05%
5-Year Total Return
--
52-week Low
Apr 07, 2025 - $0.78
52-week High
Jan 06, 2026 - $25.00
Valuation
Market Cap
$995.17M - Small Cap
Enterprise Value
$812.56M
Price/Sales (TTM)
--
Price/Book (Q)
5.17
Dividends and Shares
Shares Outstanding
71.30M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
ventyxbio.com
Phone Number
760 593 4832
Address
12790 El Camino Real
San Diego, CA 92130
Country
United States
Year Founded
2018
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops oral therapies for patients with autoimmune, inflammatory, and neurodegenerative diseases. The company’s lead... more
NASDAQ 01/22/2026 2:45PM Eastern Quotes delayed